Engineered Biosynthesis of Pharmaceutically Important Compounds.

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Synthetic Biology

Background:

• Natural products are vital sources of medicines.
• Novel biosynthetic enzymes are key biocatalysts for synthesizing valuable natural products.
• Advances in genetics and structural biology facilitate enzyme engineering for creating unnatural bioactive compounds.

Purpose of the Study:

• To review recent advancements in discovering and engineering natural product biosynthetic enzymes.
• To highlight the exploitation of a novel enzyme in sulfonamide antibiotic SB-203208 biosynthesis.
• To demonstrate the production of unnatural bioactive depsipeptides via microbial assembly line reconstruction.

Main Methods:

• Exploitation of novel secondary metabolite enzymes.
• Enzyme engineering using genetics and structural biology.
• Reconstruction of modular enzyme assembly lines in microbial hosts.

Main Results:

• Identification and utilization of a novel enzyme in the biosynthesis of sulfonamide antibiotic SB-203208.
• Successful production of unnatural bioactive depsipeptides through engineered microbial systems.
• Demonstration of enzyme engineering capabilities for novel compound synthesis.

Conclusions:

• Novel natural enzymes offer significant potential as biocatalysts.
• Enzyme engineering is a powerful strategy for producing unnatural bioactive molecules.
• Reconstructing biosynthetic pathways in microbes enables efficient synthesis of complex natural products and analogs.